# Co-Diagnostics, Inc.: filings

CODX · Nasdaq · CIK 1692415 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/codx.md) · [Financials](/companies/codx/financials.md) · [Filings](/companies/codx/filings.md) · [Insiders](/companies/codx/insiders.md)

## Reports and events: 138 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 141, 8-K 83, 10-Q 28, 3 15, 424B5 11, CORRESP 10, DEF 14A 10, 10-K 9, UPLOAD 9, SC 13G 8, EFFECT 7, SC 13G/A 7, S-3 6, SCHEDULE 13G/A 6, PRE 14A 5, S-1/A 4, SCHEDULE 13G 4, DRS 3, S-8 3, 424B4 2, 4/A 2, 8-K/A 2, D 2, DEFA14A 2, 10-Q/A 1, 5 1, 8-A12B 1, CERTNAS 1, DRS/A 1, DRSLTR 1, FWP 1, S-1 1, S-8 POS 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-15 | 16:15 ET | [8-K](/filings/0001493152-26-047242.md) | 5.07 Shareholder vote results | 0001493152-26-047242 |
| 2026-10-15 | 06:10 ET | [8-K/A](/filings/0001493152-26-047089.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-047089 |
| 2026-10-13 | 06:10 ET | [8-K](/filings/0001493152-26-046676.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-046676 |
| 2026-10-05 | 19:38 ET | [8-K](/filings/0001493152-26-045652.md) | 5.07 Shareholder vote results | 0001493152-26-045652 |
| 2026-09-25 | 16:45 ET | [8-K](/filings/0001493152-26-044346.md) | 5.07 Shareholder vote results | 0001493152-26-044346 |
| 2026-09-16 | 10:30 ET | [8-K](/filings/0001493152-26-042854.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-042854 |
| 2026-09-16 | 08:45 ET | [8-K](/filings/0001493152-26-042844.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-042844 |
| 2026-09-15 | 16:05 ET | [8-K](/filings/0001493152-26-042744.md) | 8.01 Other events | 0001493152-26-042744 |
| 2026-09-04 | 16:30 ET | [8-K](/filings/0001493152-26-041560.md) | 5.02 Departure or appointment of officers or directors | 0001493152-26-041560 |
| 2026-09-04 | 09:00 ET | [8-K](/filings/0001493152-26-041468.md) | 5.07 Shareholder vote results | 0001493152-26-041468 |
| 2026-08-13 | 16:10 ET | [10-Q](/filings/0001493152-26-037762.md) | Quarterly report, period 2026-06-30 | 0001493152-26-037762 |
| 2026-08-13 | 16:03 ET | [8-K](/filings/0001493152-26-037739.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-037739 |
| 2026-07-31 | 08:30 ET | [8-K](/filings/0001493152-26-035553.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-035553 |
| 2026-07-27 | 17:05 ET | [8-K](/filings/0001493152-26-034837.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-034837 |
| 2026-07-21 | 09:00 ET | [DEF 14A](/filings/0001493152-26-034021.md) | Proxy statement, period 2026-07-21 | 0001493152-26-034021 |
| 2026-05-21 | 08:00 ET | [8-K](/filings/0001493152-26-024738.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-024738 |
| 2026-05-14 | 16:10 ET | [10-Q](/filings/0001493152-26-023085.md) | Quarterly report, period 2026-03-31 | 0001493152-26-023085 |
| 2026-05-14 | 16:05 ET | [8-K](/filings/0001493152-26-023059.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-023059 |
| 2026-03-31 | 16:10 ET | [10-K](/filings/0001493152-26-014158.md) | Annual report, period 2025-12-31 | 0001493152-26-014158 |
| 2026-03-31 | 16:05 ET | [8-K](/filings/0001493152-26-014129.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-014129 |
| 2026-03-10 | 09:25 ET | [8-K](/filings/0001493152-26-009478.md) | 2.02 Results of operations; 8.01 Other events | 0001493152-26-009478 |
| 2026-01-13 | 12:23 ET | [8-K](/filings/0001493152-26-001971.md) | 3.01 Delisting notice | 0001493152-26-001971 |
| 2025-12-30 | 09:15 ET | [8-K](/filings/0001493152-25-029513.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-029513 |
| 2025-12-05 | 16:30 ET | [8-K](/filings/0001493152-25-026385.md) | 5.07 Shareholder vote results | 0001493152-25-026385 |
| 2025-11-13 | 16:10 ET | [10-Q](/filings/0001493152-25-022300.md) | Quarterly report, period 2025-09-30 | 0001493152-25-022300 |
| 2025-11-13 | 16:03 ET | [8-K](/filings/0001493152-25-022283.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-022283 |
| 2025-11-10 | 17:15 ET | [DEF 14A](/filings/0001493152-25-021564.md) | Proxy statement, period 2025-11-10 | 0001493152-25-021564 |
| 2025-10-29 | 17:05 ET | [8-K](/filings/0001493152-25-020100.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-020100 |
| 2025-10-20 | 09:42 ET | [8-K](/filings/0001493152-25-018591.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001493152-25-018591 |
| 2025-09-30 | 09:32 ET | [8-K](/filings/0001493152-25-016211.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-016211 |
| 2025-09-18 | 08:45 ET | [8-K](/filings/0001493152-25-013981.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-013981 |
| 2025-08-14 | 16:11 ET | [10-Q](/filings/0001641172-25-024029.md) | Quarterly report, period 2025-06-30 | 0001641172-25-024029 |
| 2025-08-14 | 16:01 ET | [8-K](/filings/0001641172-25-023968.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-023968 |
| 2025-07-11 | 16:15 ET | [8-K](/filings/0001641172-25-018753.md) | 8.01 Other events | 0001641172-25-018753 |
| 2025-05-29 | 16:30 ET | [8-K](/filings/0001641172-25-012871.md) | 5.07 Shareholder vote results | 0001641172-25-012871 |
| 2025-05-08 | 16:10 ET | [10-Q](/filings/0001641172-25-009257.md) | Quarterly report, period 2025-03-31 | 0001641172-25-009257 |
| 2025-05-08 | 16:05 ET | [8-K](/filings/0001641172-25-009249.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-009249 |
| 2025-04-28 | 07:00 ET | [8-K](/filings/0001641172-25-006324.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-006324 |
| 2025-04-14 | 16:30 ET | [DEF 14A](/filings/0001641172-25-004580.md) | Proxy statement, period 2024-12-31 | 0001641172-25-004580 |
| 2025-03-27 | 16:10 ET | [10-K](/filings/0001641172-25-000932.md) | Annual report, period 2024-12-31 | 0001641172-25-000932 |
| 2025-03-27 | 16:05 ET | [8-K](/filings/0001641172-25-000922.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-000922 |
| 2025-02-21 | 17:15 ET | [8-K](/filings/0001493152-25-007919.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-007919 |
| 2025-01-10 | 16:15 ET | [8-K](/filings/0001493152-25-001705.md) | 3.01 Delisting notice | 0001493152-25-001705 |
| 2024-11-08 | 16:15 ET | [8-K/A](/filings/0001493152-24-044279.md) | 5.07 Shareholder vote results | 0001493152-24-044279 |
| 2024-11-07 | 16:05 ET | [10-Q](/filings/0001493152-24-044008.md) | Quarterly report, period 2024-09-30 | 0001493152-24-044008 |
| 2024-11-07 | 16:01 ET | [8-K](/filings/0001493152-24-044001.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-044001 |
| 2024-08-30 | 16:30 ET | [8-K](/filings/0001493152-24-034599.md) | 5.07 Shareholder vote results | 0001493152-24-034599 |
| 2024-08-08 | 16:06 ET | [10-Q](/filings/0001493152-24-030758.md) | Quarterly report, period 2024-06-30 | 0001493152-24-030758 |
| 2024-08-08 | 16:01 ET | [8-K](/filings/0001493152-24-030746.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-030746 |
| 2024-07-16 | 16:15 ET | [DEF 14A](/filings/0001493152-24-028019.md) | Proxy statement, period 2024-07-16 | 0001493152-24-028019 |

Page 1 of 3. [Older](/companies/codx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 16:01 ET. No prices; not investment advice.